Filter posts

More than a Quarter of 2013 US-Based Biotech IPOs Call California Home

And of those 39 US-based biotech companies, five of them are from San Diego, highlighting …

Ask CA Governor Brown To Sign SB 598

California’s Assembly and Senate have both overwhelmingly passed Senate Bill 598, legislation that creates a …

State Legislation Needed For Substitution of Interchangeable Biologics

A great deal of the media coverage relating to California’s Senate Bill 598 ┬áneglects to …

California Continues Responsible Support for Interchangeability of Biologic Drugs

Yesterday, California’s State Assembly Committee on Appropriations took another decisive step when they unanimously voted …

CHI Program to Offer Tips for Acquiring Pipeline Funding

Biomedical innovations rely largely on scientific breakthroughs, which in turn happen through well-structured research programs. …

California Biomedical Companies Cite Lack Of Funding As Major Concern

As I have mentioned in past blog posts, the U.S. bioscience industry has demonstrated stability …

BayBio Announces Lifetime Achievement DiNA Award Recipient

Dr. Michael Hunkapiller has been named BayBio’s 2011 Lifetime Achievement DiNA Award recipient. He will …